Center for Translational Injury Research, Division of Acute Care Surgery, Department of Surgery, Medical School, University of Texas Health Science Center at Houston, Houston, Texas 77030, USA.
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S24-30. doi: 10.1097/TA.0b013e31828fa3b9.
The trauma transfusion literature has yet to resolve which is more important for hemorrhaging patients, transfusing plasma and platelets along with red blood cells (RBCs) early in resuscitation or gradually balancing blood product ratios. In a previous report of PROMMTT results, we found (1) plasma and platelet:RBC ratios increased gradually during the 6 hours following admission, and (2) patients achieving ratios more than 1:2 (relative to ratios <1:2) had significantly decreased 6-hour to 24-hour mortality adjusting for baseline and time-varying covariates. To differentiate the association of in-hospital mortality with early plasma or platelet transfusion from that with delayed but gradually balanced ratios, we developed a separate analytic approach.
Using PROMMTT data and multilevel logistic regression to adjust for center effects, we related in-hospital mortality to the early receipt of plasma or platelets within the first three to six transfusion units (including RBCs) and 2.5 hours of admission. We adjusted for the same covariates as in our previous report: Injury Severity Score (ISS), age, time and total number of blood product transfusions upon entry to the analysis cohort, and bleeding from the head, chest, or limb.
Of 1,245 PROMMTT patients, 619 were eligible for this analysis. Early plasma was associated with decreased 24-hour and 30-day mortality (adjusted odds ratios of 0.47 [p = 0.009] and 0.44 [p = 0.002], respectively). Too few patients (24) received platelets early for meaningful assessment. In the subgroup of 222 patients receiving no early plasma but continuing transfusions beyond Hour 2.5, achieving gradually balanced plasma and platelet:RBC ratios of 1:2 or greater by Hour 4 was not associated with 30-day mortality (adjusted odds ratios of 0.9 and 1.1, respectively). There were no significant center effects.
Plasma transfusion early in resuscitation had a protective association with mortality, whereas delayed but gradually balanced transfusion ratios did not. Further research will require considerably larger numbers of patients receiving platelets early.
在创伤输血文献中,对于出血患者,在复苏早期同时输注血浆和血小板以及红细胞(RBC),还是逐渐平衡血液制品比例更为重要,这一问题尚未得到解决。在之前 PROMMTT 研究结果的报告中,我们发现:(1)在入院后 6 小时内,血浆和血小板:RBC 比值逐渐增加;(2)与比值<1:2 的患者相比,达到比值>1:2 的患者在调整基线和时变协变量后,6 小时至 24 小时死亡率显著降低。为了区分早期输注血浆或血小板与延迟但逐渐平衡的比值与住院死亡率的关联,我们采用了一种单独的分析方法。
使用 PROMMTT 数据和多水平逻辑回归来调整中心效应,我们将住院死亡率与入院后前 3 至 6 个单位输血(包括 RBC)内以及入院后 2.5 小时内早期输注血浆或血小板的情况相关联。我们调整了与之前报告相同的协变量:损伤严重程度评分(ISS)、年龄、时间以及进入分析队列时输入的总血液制品输注次数,以及头部、胸部或四肢的出血。
在 1245 名 PROMMTT 患者中,有 619 名符合本分析的条件。早期输注血浆与降低 24 小时和 30 天死亡率相关(调整后的优势比分别为 0.47[P=0.009]和 0.44[P=0.002])。只有 24 名患者早期接受了足够数量的血小板,无法进行有意义的评估。在 222 名未早期输注血浆但在入院后 2.5 小时后继续输血的患者亚组中,在入院后 4 小时达到逐渐平衡的血浆和血小板:RBC 比值 1:2 或更高,与 30 天死亡率无关(调整后的优势比分别为 0.9 和 1.1)。中心效应无显著差异。
在复苏早期输注血浆与死亡率呈保护相关,而延迟但逐渐平衡的输血比例则无此关联。进一步的研究需要有相当数量的患者早期接受血小板输注。